Table 3. Influence of the chemotherapeutic initial dose on cytokines and complement components C3, C4, as well as the activation fragment C4d.
Before initial dose
|
After initial dose
|
Paired Student's t-test | |||||
---|---|---|---|---|---|---|---|
Mean | s.d. | Units | Mean | s.d. | units | P-value | |
Cytokine panel | |||||||
Discovery set (n=12) | |||||||
TNFα | ND | pg ml−1 | ND | pg ml−1 | — | ||
TNFβ | ND | pg ml−1 | ND | pg ml−1 | — | ||
IFNγ | ND | pg ml−1 | ND | pg ml−1 | — | ||
IL-1β | ND | pg ml−1 | ND | pg ml−1 | — | ||
IL-2 | 27.7 | 29.4 | pg ml−1 | 24.6 | 36.4 | pg ml−1 | 0.491 |
IL-4 | ND | pg ml−1 | ND | pg ml−1 | — | ||
IL-5 | ND | pg ml−1 | ND | pg ml−1 | — | ||
IL-6 | 1.0 | 0.01 | pg ml−1 | 4.5 | 1.6 | pg ml−1 | 0.003 |
IL-8 | 2.6 | 17.6 | pg ml−1 | 23.1 | 30.7 | pg ml−1 | 0.268 |
IL-10 | 5.1 | 1.0 | pg ml−1 | 8.5 | 3.5 | pg ml−1 | 0.001 |
IL-12p70 | ND | pg ml−1 | ND | pg ml−1 | — | ||
sE-selectin | 86.7 | 52.5 | ng ml−1 | 88.8 | 55.5 | ng ml−1 | 0.179 |
sICAM-1 | 453.5 | 177.4 | ng ml−1 | 413.1 | 146.8 | ng ml−1 | 0.181 |
sICAM-3 | 87.6 | 23.8 | ng ml−1 | 64.1 | 20.7 | ng ml−1 | 0.011 |
sPECAM-1 | 200.4 | 93.5 | ng ml−1 | 139.4 | 61.7 | ng ml−1 | 0.069 |
sP-selectin | 428.5 | 182.5 | ng ml−1 | 405 | 130.9 | ng ml−1 | 0.178 |
sVCAM-1 | 420.8 | 622.4 | ng ml−1 | 468.4 | 259.7 | ng ml−1 | 0.288 |
Complement factors | |||||||
Discovery set (n=12) | |||||||
C3 | 144.2 | 15.40 | mg per 100 ml | 127.9 | 17.3 | mg per 100 ml | 0.002 |
C4 | 30.4 | 6.00 | mg per 100 ml | 24.5 | 6.8 | mg per 100 ml | <0.001 |
C4d | 3.6 | 1.40 | μg ml−1 | 2.6 | 1.0 | μg ml−1 | 0.007 |
Validation set (n=13) | |||||||
C3 | 124.6 | 16.50 | mg per 100 ml | 118.1 | 19.3 | mg per 100 ml | 0.011 |
C4 | 27.0 | 5.90 | mg per 100 ml | 23.5 | 5.3 | mg per 100 ml | 0.019 |
C4d | 2.8 | 1.00 | μg ml−1 | 2.2 | 0.8 | μg ml−1 | 0.004 |
Abbreviation: ND=not detectable.